US Patent Issued to Quest Diagnostics Investments on May 20 for "EML4-ALK translocations in lung cancer" (California, Virginia Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,305,241, issued on May 20, was assigned to Quest Diagnostics Investments LLC (Secaucus, N.J.).

"EML4-ALK translocations in lung cancer" was invented by Heather R. Sanders (Winchester, Calif.), Maher Albitar (Coto De Caza, Calif.) and Aurelia Meloni-Ehrig (Gainesville, Va.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to methods for the diagnosis and evaluation of neoplastic disorders, particularly non-small cell lung cancer. Assays are described in which patient test samples are analyzed for the presence of one or more specific EML4-ALK fusion genes associated with neoplastic disorders."

The patent was filed on May 1, 20...